ziftomenib
kura oncology
['ko,met,001', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'komet-001', 'ziftomenib', 'ko,met,01', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
#ziftomenib appeared safe and effective in heavily pretreated and co-mutated patients with npm1-mutated, relapsed/refractory #aml, according to phase 1 data from the komet-001 trial. #eha2023 #leusm | 
Oncology news and insights from leading researchers and cancer centers.